| Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients CA Pierce, P Preston-Hurlburt, Y Dai, CB Aschner, N Cheshenko, B Galen, ... Science translational medicine 12 (564), eabd5487, 2020 | 344 | 2020 |
| Human α-and β-defensins block multiple steps in herpes simplex virus infection E Hazrati, B Galen, W Lu, W Wang, Y Ouyang, MJ Keller, RI Lehrer, ... The Journal of Immunology 177 (12), 8658-8666, 2006 | 341 | 2006 |
| HIV-infected liver and kidney transplant recipients: 1-and 3-year outcomes ME Roland, B Barin, L Carlson, LA Frassetto, NA Terrault, R Hirose, ... American Journal of Transplantation 8 (2), 355-365, 2008 | 279 | 2008 |
| Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID‐19 MJ Keller, EA Kitsis, S Arora, JT Chen, S Agarwal, MJ Ross, Y Tomer, ... Journal of hospital medicine 15 (8), 489-493, 2020 | 153 | 2020 |
| Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial OC Aroniadis, LJ Brandt, C Oneto, P Feuerstadt, A Sherman, AW Wolkoff, ... The Lancet Gastroenterology & Hepatology 4 (9), 675-685, 2019 | 150 | 2019 |
| Natural mucosal barriers and COVID-19 in children CA Pierce, S Sy, B Galen, DY Goldstein, E Orner, MJ Keller, KC Herold, ... JCI insight 6 (9), 2021 | 143 | 2021 |
| Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety PMM Mesquita, N Cheshenko, SS Wilson, M Mhatre, E Guzman, ... The Journal of infectious diseases 200 (4), 599-608, 2009 | 139 | 2009 |
| PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity MJ Keller, E Guzman, E Hazrati, A Kasowitz, N Cheshenko, S Wallenstein, ... Aids 21 (4), 467-476, 2007 | 138 | 2007 |
| Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action IA Scordi-Bello, A Mosoian, C He, Y Chen, Y Cheng, GA Jarvis, MJ Keller, ... Antimicrobial agents and chemotherapy 49 (9), 3607-3615, 2005 | 131 | 2005 |
| TLR7 induces anergy in human CD4+ T cells M Dominguez-Villar, AS Gautron, M De Marcken, MJ Keller, DA Hafler Nature immunology 16 (1), 118-128, 2015 | 121 | 2015 |
| Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread N Cheshenko, MJ Keller, V MasCasullo, GA Jarvis, H Cheng, M John, ... Antimicrobial agents and chemotherapy 48 (6), 2025-2036, 2004 | 110 | 2004 |
| PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial MJ Keller, B Zerhouni-Layachi, N Cheshenko, M John, K Hogarty, ... The Journal of infectious diseases 193 (1), 27-35, 2006 | 108 | 2006 |
| Seminal plasma reduces the effectiveness of topical polyanionic microbicides S Patel, E Hazrati, N Cheshenko, B Galen, H Yang, E Guzman, R Wang, ... The Journal of infectious diseases 196 (9), 1394-1402, 2007 | 107 | 2007 |
| Risk factors for decreased bone density and effects of HIV on bone in the elderly S Jones, D Restrepo, A Kasowitz, D Korenstein, S Wallenstein, ... Osteoporosis International 19, 913-918, 2008 | 106 | 2008 |
| Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection M John, MJ Keller, EH Fam, N Cheshenko, K Hogarty, A Kasowitz, ... The Journal of infectious diseases 192 (10), 1731-1740, 2005 | 101 | 2005 |
| Male sexual dysfunction associated with antiretroviral therapy AE Colson, MJ Keller, PE Sax, PT Pettus, R Platt, PW Choo JAIDS Journal of Acquired Immune Deficiency Syndromes 30 (1), 27-32, 2002 | 99 | 2002 |
| A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel MJ Keller, RP Madan, NM Torres, MJ Fazzari, S Cho, S Kalyoussef, ... PloS one 6 (1), e16475, 2011 | 92 | 2011 |
| Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection MJ Keller, RD Burk, X Xie, K Anastos, LS Massad, H Minkoff, X Xue, ... Jama 308 (4), 362-369, 2012 | 87 | 2012 |
| Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions S Kalyoussef, E Nieves, E Dinerman, C Carpenter, V Shankar, J Oh, ... PloS one 7 (11), e49506, 2012 | 84 | 2012 |
| A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety BT Galen, AP Martin, E Hazrati, A Garin, E Guzman, SS Wilson, DD Porter, ... The Journal of infectious diseases 195 (9), 1332-1339, 2007 | 84 | 2007 |
